3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
2
Endocrine
2
Thoracic
1
Sarcoma
1
NET
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Cisplatin
88
pembrolizumab
83
Magnetic Resonance Spectroscopy
47
Radiotherapy, Intensity-Modulated
41
Carboplatin
38
Specimen Handling
37
Cetuximab
36
Radiotherapy
35
Nivolumab
29
Paclitaxel
25
Platinum
23
Radiation
22
Docetaxel
22
Gemcitabine
21
Biopsy
21
1,2-diaminocyclohexaneplatinum II citrate
21
Surveys and Questionnaires
17
Fluorouracil
15
Standard of Care
13
toripalimab
12
Taxes
11
cemiplimab
10
Surgical Procedures, Operative
10
Cyclophosphamide
10
atezolizumab
9
X-Rays
9
Ipilimumab
9
Immunoglobulin G
9
Drug Therapy
9
Capecitabine
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radionuclide Imaging
×
Head & Neck
×
90 days
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled